Emfizatamab Biosimilar - Anti-CD3e,CD19,CD274,TNFRSF9 mAb - Research Grade, Monoclonal

Product Overview

• Article Name: Emfizatamab Biosimilar - Anti-CD3e,CD19,CD274,TNFRSF9 mAb - Research Grade, Monoclonal
• Biozol Catalog Number: PTG-PX-TA1893-1MG
• Supplier Catalog Number: PX-TA1893-1MG
• Alternative Catalog Number: PTG-PX-TA1893-1MG
• Manufacturer: ProteoGenix
• Category: Antikörper
• Species Reactivity: Human
• Alternative Names: Anti-CD19, Anti-PD-L1, Anti-CD137, GNC 038, GNC-038, GNC038, CAS: 2559704-23-1

Product Properties

• Clonality: Monoclonal
• UniProt: P15391
• Buffer: 0.01M PBS, pH 7.4.
• Expression System: Eukaryotic expression
• Target: CD19 & PD-L1 & CD3E & CD137